Mercer Global Advisors
IBIO icon

Mercer Global Advisors’s iBio IBIO Stock Holding History

Mercer Global Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12 Buy
+7
New +$13 ﹤0.01% 6051

Other funds holding IBIO

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Mercer Global Advisors's IBIO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in iBio (IBIO) in Q2 2026: 7 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #6051 among its holdings.

15 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Mercer Global Advisors held 7 shares of iBio worth $12 as of Q2 2026.
  • iBio was a new Mercer Global Advisors position in Q2 2026.
  • iBio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6051 holding.
  • 15 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.